Verified Peptide ReviewLast reviewed: 18 March 2026
Compound Profile · Recovery
TB-500
TB-500 is a synthetic peptide fragment of thymosin beta-4, studied in research models for cell migration, angiogenesis and tissue regeneration.
LegalResearch onlyEvidenceStrongHuman useNot approved
8.8/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Often paired with BPC-157 in research literature. Mechanistic data is interesting but human clinical evidence is limited.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full TB-500 review
TB-500 corresponds to a section of thymosin beta-4, a naturally occurring protein.
It is studied for actin regulation, cell migration and tissue repair pathways.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.